Structure of human PD-L1 in complex with clinically evaluated inhibitor

Structure of human PD-L1 in complex with clinically evaluated inhibitor Descriptor: (3~{R})-1-[[7-(iminomethyl)-2-[2-methyl-3-[2-methyl-3-[[3-[[(3~{R})-3-oxidanylpyrrolidin-1-yl]methyl]-1,7-naphthyridin-8-yl]amino]phenyl]phenyl]-1,3-benzoxazol-5-yl]methyl]pyrrolidine-3-carboxylic acid, Programmed cell death 1 ligand 1 Authors: Plewka, J, Golebiowska-Mendroch, K, Slota, A, Magiera-Mularz, K. Deposit date: 2025-01-15 Release date: 2025-06-18 Last modified: 2025-07-30 Method: X-RAY DIFFRACTION (2.1 Å) Cite: Characterization of Clinically Evaluated Small-Molecule Inhibitors of PD-L1 for Immunotherapy. Acs Med.Chem.Lett., 16, 2025